Old National Bancorp’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-9,059
Closed -$537K 569
2018
Q4
$537K Sell
9,059
-1,045
-10% -$67.4K 0.03% 316
2018
Q3
$665K Hold
10,104
0.03% 313
2018
Q2
$510K Hold
10,104
0.03% 362
2018
Q1
$532K Buy
10,104
+74
+0.7% +$3.69K 0.03% 344
2017
Q4
$466K Buy
+10,030
New +$422K 0.02% 385

Other funds holding EBS

Old National Bancorp's EBS Position: Q1 2019 in Review

Old National Bancorp sold out of Emergent Biosolutions (EBS) in Q1 2019, closing a stake of 9,059 shares — an estimated $537K sold.

Old National Bancorp first reported a position in EBS in Q4 2017 and held it in 5 quarters. The position peaked at $665K in Q3 2018. 272 funds tracked by Wall St. Rank hold EBS as of Q1 2019.

  • Old National Bancorp reported no remaining Emergent Biosolutions position as of Q1 2019 after selling out during the quarter.
  • Old National Bancorp sold 9,059 Emergent Biosolutions shares in Q1 2019, an estimated $537K.
  • Old National Bancorp first reported a position in Emergent Biosolutions in Q4 2017 and held it in 5 quarters.
  • Old National Bancorp's Emergent Biosolutions position peaked at $665K in Q3 2018.
  • 272 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2019.

Based on Old National Bancorp's 13F filing for Q1 2019, filed 30 Apr 2019.